ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Endoscopic Sinus Surgery Superior to Two of Three Biologics in Treating Severe Chronic Rhinosinusitis with Nasal Polyps

by Linda Kossoff • April 25, 2023

  • Tweet
  • Email
Print-Friendly Version

How does endoscopic sinus surgery (ESS) with appropriate ongoing medical management compare with biologics use as a treatment for patients with severe nasal polyposis?

BOTTOM LINE:

You Might Also Like

No related posts.

Explore This Issue
April 2023

At 24 and 52 weeks, ESS and dupilumab are comparable; ESS offers some improvements compared to dupilumab, omalizumab, and mepolizumab.

BACKGROUND: Approximately 25% of patients with chronic rhinosinusitis (CRS) suffer from nasal polyposis. Several biologics have demonstrated benefits in measures of CRS disease severity. Although both biologics and ESS are treatment options for patients with severe CRS with nasal polyps (CRSwNP), direct prospective comparative studies between the two do not exist.

STUDY DESIGN: Prospective cohort study.

SETTING: Department of Otolaryngology–Head and Neck Surgery, Medical University of South Carolina, Charleston, S.C.

SYNOPSIS: Study participants diagnosed with severe CRSwNP were enrolled in a multicenter observational cohort study evaluating outcomes following ESS from April 2011 to August 2019. Within the cohort, 111 patients (53% male, mean age 51.9 years) met inclusion criteria. Participants were asked to complete both preoperative and postoperative evaluations. In addition, data from five recently published phase 3 randomized controlled clinical trials investigating use of dupilumab, omalizumab, and mepolizumab in severe CRSwNP were reviewed. Baseline characteristics and outcome measures were compared between these cohorts at 24 weeks and 52 weeks, when possible. At 24 weeks, ESS demonstrated significantly greater improvement in Sino-Nasal Outcome Test (SNOT-22) scores compared to one of two dupilumab trials and both omalizumab trials; at 52 weeks, ESS resulted in statistically similar improvement in SNOT-22 scores compared to dupilumab. At 24 weeks, nasal polyp scores (NPS) in the ESS cohort were significantly lower compared to dupilumab and omalizumab trials; at 52 weeks, NPS were lower in the ESS group than dupilumab and mepolizumab. Study limitations included loss to follow-up for patients in the ESS cohort.

CITATION: Miglani A, Soler ZM, Smith TL, et al. A comparative analysis of endoscopic sinus surgery versus biologics for treatment of chronic rhinosinusitis with nasal polyposis. Int Forum Allergy Rhinol. 2023;13:116–128.

Filed Under: Literature Reviews, Practice Focus, Rhinology, Rhinology Tagged With: clinical outcomes, rhinologyIssue: April 2023

You Might Also Like:

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Second Victims: The Effects of a Medical Error on Physicians Can Be Devastating
    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?
    • Keeping Watch for Skin Cancers on the Head and Neck
    • Complications for When Physicians Change a Maiden Name
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?
    • Vertigo in the Elderly: What Does It Mean?
    • What Happens to Medical Students Who Don’t Match?
    • Complications for When Physicians Change a Maiden Name
    • Qualitative Research Shows How Patients Feel About Quality-of-Life Issues
    • How to: A Dynamic Endonasal Columellar Strut Placement
    • Second Victims: The Effects of a Medical Error on Physicians Can Be Devastating
    • Advanced Degrees Can Help Otolaryngologists Better Understand the Business of Medicine
    • Laser Laryngeal Surgery Is Safe Under THRIVE

Polls

Have you ever been, or have you ever known someone who has been a second victim?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2023 The Triological Society. All Rights Reserved.
ISSN 1559-4939